Last month, Google announced plans to acquire Israeli cloud cybersecurity firm Wiz for an estimated $32 billion – making this its biggest acquisition ever.
B of A Securities maintained a Buy rating on Procter & Gamble Co. (NYSE: PG) while cutting its price target to $180. Analyst Bryan D. Spillane highlighted tariff risks possibly impacting margins and reducing EPS for FY25 and FY26. PG expects to counter rising costs via favorable FX, reduced commodity expenses, and pricing moves. Demand remains stable, with growth seen in China and Latin America.
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's decision on semaglutide shortage.
Palantir Technologies have surged 19% this week, trading above $110 Friday afternoon. Investors have responded positively to a combination of geopolitical developments and major defense partnerships.
Shares of health coverage company Centene (NYSE:CNC)
fell 7.6% in the morning session after the company reported a mixed first-quarter 2025 performance: a decline in total customers and a slightly weaker full-year earnings outlook cast a shadow over the results. On the other hand, revenue and adjusted EPS both beat expectations. Overall, we think this was a weaker quarter.
Shares of transportation and logistics solutions provider Universal Logistics (NASDAQ:ULH)
fell 9.1% in the morning session after the company reported weak first-quarter 2025 results, as both revenue and EBITDA fell well below Wall Street's expectations. Sales fell across every major segment: contract logistics, the company's largest line, shrank 18%, while intermodal and trucking dropped nearly 10% and 20%, respectively.
Management acknowledged the sluggish start but pointed to improving trends later in the quarter, and emphasized plans to restructure underperforming operations and pursue new customer wins.
Still, with no guidance issued and visibility into a rebound unclear, the quarter offered little to ease concerns about the company's path back to growth.
Shares of life sciences company Avantor (NYSE:AVTR)
fell 21.2% in the afternoon session after the company reported a weak first-quarter 2025 performance, as its organic revenue and total sales both missed Wall Street's expectations. Sales dropped 6% from a year ago, reflecting softness across both major business segments. Lab Solutions declined 8% while Bioscience Production slipped slightly.
Encouragingly, management raised its cost savings target to $400 million by 2027 and signaled urgency to fix performance issues in the Lab Solutions segment.
Overall, this was a softer quarter.
Shares of cable, internet, and telephone services provider Charter (NASDAQ:CHTR)
jumped 11.2% in the afternoon session after the company reported strong first-quarter 2025 results, with earnings and EBITDA exceeding analysts' estimates, signaling improved cost control and solid profit growth. On the other hand, its number of internet subscribers missed. Zooming out, we think this was a decent quarter featuring some areas of strength but also some blemishes.
